Literature DB >> 9015515

Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania.

J Curtis1, M T Duraisingh, J K Trigg, H Mbwana, D C Warhurst, C F Curtis.   

Abstract

A nested polymerase chain reaction was used to amplify a fragment of the gene for dihydrofolate reductase of Plasmodium falciparum containing codon 108, where a point mutation, causing a serine to asparagine change, occurs in pyrimethamine resistant parasites. The presence of the mutation was detected by restriction enzyme digestion. Parasites in blood samples collected from asymptomatic children before, and 3 weeks after, treatment with pyrimethamine-sulfadoxine or chlorproguanil-dapsone were analysed. Parasites in the samples taken at 3 weeks carried only the asparagine mutant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9015515     DOI: 10.1016/s0035-9203(96)90432-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.

Authors:  Florian Marks; Jennifer Evans; Christian G Meyer; Edmund N Browne; Christa Flessner; Vera von Kalckreuth; Teunis A Eggelte; Rolf D Horstmann; Jürgen May
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.

Authors:  Zhiyong Zhou; Amanda C Poe; Josef Limor; Katharine K Grady; Ira Goldman; Andrea M McCollum; Ananias A Escalante; John W Barnwell; Venkatachalam Udhayakumar
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

3.  Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.

Authors:  Gwladys Bertin; Valérie Briand; Diana Bonaventure; Ambre Carrieu; Achille Massougbodji; Michel Cot; Philippe Deloron
Journal:  Malar J       Date:  2011-07-19       Impact factor: 2.979

4.  Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe.

Authors:  Tomas Jelinek; Gabriele Peyerl-Hoffmann; Nikolai Mühlberger; Ole Wichmann; Michael Wilhelm; Nadja Schmider; Martin P Grobusch; Frank von Sonnenburg; Joaquim Gascon; Hermann Laferl; Christoph Hatz; Michael Alifrangis; Gerd Burchard; Paul McWhinney; Marco Schulze; Herwig Kollaritsch; Saraiva da Cunha; Jiri Beran; Peter Kern; Ida Gjørup; Juan Cuadros
Journal:  Malar J       Date:  2002-10-11       Impact factor: 2.979

5.  Molecular epidemiology of drug-resistant malaria in western Kenya highlands.

Authors:  Daibin Zhong; Yaw Afrane; Andrew Githeko; Liwang Cui; David M Menge; Guiyun Yan
Journal:  BMC Infect Dis       Date:  2008-07-31       Impact factor: 3.090

6.  Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.

Authors:  Philippe Deloron; Gwladys Bertin; Valérie Briand; Achille Massougbodji; Michel Cot
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.